The rheumatoid factor (RF) levels of IgM-RF and IgG-RF types in sera from patients with spinal cord injuries (SCI) and osteochondrosis were investigated by ELISA. According to the findings in the late stages of the disease, SCI patients showed 46% seropositiveness for IgG-RF and 40% for IgM-RF. Patients with fresh central nervous system (CNS) injuries were 12% and 14% seropositive, respectively. Patients with osteochondrosis exhibited 33% seropositiveness for IgG-RF. The determination of serum RF enables us to identify the systemic body lesion in the SCI late stages as a rheumatoid disease. These data support the conclusion that RF determination is a reliable serological indicator of the severity of a patient's traumatic disease.
Introduction
In the late stages of disease many SCI patients exhibit systemic lesions of the visceral organs along with disturbed motor activity. Taking into consideration the sev erity of a number of symptoms, spinal cord trauma in the advanced stages can be referred to autoimmune disorders. Chronic inflammation and significant immune sys tem disorders in injuryu suggest involve ment of antibodies to autologous immuno globulins (the RF) in pathological develop ment. 3 To clarify the role of RF in spinal cord trauma in the late stages, serum RF levels of IgG and IgM were investigated, and it was speculated that such studies could be used prognostically to predict the out come of SCI patients.
Patients and methods
IgM-RF and IgG-RF serum levels were determined in the patient groups as follows:
(1) spinal cord trauma in the late stages (4 or more months after injury); (2) spinal injury in the early stages (within 2 weeks of injury); (3) craniocerebral injury; (4) spinal pathological states (osteochondrosis). RF was determined by ELISA. To create the immunoenzyme system our own and com mercial reagents were used: (1) Fe-fragment of human IgG; (2) staphylococcal protein A and horse radish peroxidase conjugate; (3) substrate mixture -orthophenylenediamine and hydrogen peroxide solution; (4) car rier-polystyrene 96-well pans (Titertek').
The ELISA data were recorded on a Titer tek multiscan photometer at 492 nm wavelength. RF preparations, isolated and purified by affinity chromatography from seropositive sera of rheumatoid arthritis (RA) patients and RA patients' sera, were used as positive controls. IgG and IgM preparations, isolated from normal human sera and from the sera pooled of healthy blood donors, were used as negative con trols. Seventy-nine serum samples from patients with CNS injuries and nontraumatic spinal cord diseases, and samples from healthy blood donors were analysed by ELISA. The ratio between optical densities (OD) of the test sample and the diluted (1 :50) negative control serum was used as a criterion to estimate the results, according to the formula OD(x)/OD( -). The results were compared with the discriminating in dex determined in analysing sera from healthy blood donors by the formula:
where LOD(X1 -xn) = the value sum total, ODe -) = the negative control optical density, n = the number of samples from blood donors. Sera with a staining intensity exceeding the correction factor obtained in analysis of the control group are considered positive. 4
Results and discussion ELISA used in this study enabled us to detect RF of IgG-RF and IgM-RF types in patients' sera ( Table I ). The RF levels of both types with late stage SCI (group 1) significantly exceeded the levels in patients of other groups. According to the findings, estimated with respect to the discriminating index obtained from the donor sera, trauma patients were 46% seropositive for IgG-RF and 40% for IgM-RF. Patients with fresh CNS injuries (groups 2 and 3) showed low RF levels and 12-14% seropositiveness, double the RF detection frequency in healthy individuals.5 An increase of RF levels in patients with osteochondrosis (group 4), 33% seropositive for IgG-RF, IgM-RF levels in the sera from the group 1 patients compared to the donor group. Forty percent of group 1 patients were seropositive for IgM-RF. IgM-RF occur rence in patients is prognostically a hazard ous factor. 1 0 Therefore it may be concluded that in many spinal patients the complicated disease course, manifested by a number of visceral disorders, may be related to signific ant shifts in the immune system and to IgM-RF accumulation in blood.
As has been reported,10-l2 the IgG-RF level correlates with rheumatic disease in tensity. Since the disease severity in spinal patients is in many respects determined by the intensity of the inflammation, it is clear why in selected laboratory tests the inflam-mation rate and IgG-RF level were chang ing unidirectionally. IgG-RF was reported to be detected in blood after secondary immunisation, and RF formation was pre ceded by an increase in circulating immune complexes (CIC). 1 3 CIC involvement in inflammatory processes has been vali dated. 6 Following the increase in CIC level, IgG type RF is assumed to contribute to the progressive inflammation. 11, 1 4 The results of CIC level determination in spinal patients were described in our previous paper. showed a marked increase in IgG-RF: sero positiveness was 33%. This may be related to the constriction of postganglionic fibres in bony and muscular canals.
RF detection in the blood of spinal cord injury patients enables us to identify the systemic body lesion in the late stages of SCI as a disease of the rheumatoid group.
